Smoking Cessation Duration and Diabetic Microvascular Complications - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

The Impact of Smoking Cessation Duration on Microvascular Complications in Diabetes

  • By

  • Soonsu Shin

  • Min-Ho Kim

  • Jae-Hong Ryoo

  • October 2, 2026

Share

Clinical Report: The Impact of Smoking Cessation Duration on Microvascular Complications in Diabetes

Overview

This study examines the relationship between the duration of smoking cessation and the incidence of microvascular complications in patients with type 2 diabetes.

Background

Diabetes is a growing global health concern, with a significant proportion of individuals experiencing microvascular complications that severely impact quality of life. Smoking has been identified as a risk factor for these complications.

Data Highlights

No numerical data available in the provided material.

Key Findings

  • Smoking increases the risk of diabetic microvascular complications, including nephropathy, retinopathy, and neuropathy.
  • Longer durations of smoking cessation are associated with lower risks of overall microvascular complications.
  • Specifically, cessation for 8 or more years significantly reduces the risk of nephropathy and retinopathy.

Clinical Implications

Regular assessments and support for smoking cessation should be integrated into diabetes management plans.

Conclusion

The findings indicate a relationship between smoking cessation duration and the risk of microvascular complications in diabetes.

Related Resources & Content

  1. MDSpire News, 2023 -- Quitting Smoking: How Long Until CVD Risk Drops
  2. Frontiers in Endocrinology, 2026 -- Age and diabetic complications in type 2 diabetes: the role of disease duration and stage-dependent effects
  3. JAMA Network Open, 2023 -- The Importance of Smoking Cessation in the Management of Peripheral Artery Disease: The Impact of Quitting Tobacco
  4. The Journal of Clinical Endocrinology & Metabolism -- Glycemic Control Goals and Their Role in Complication Prevention
  5. American Diabetes Association, 2026 -- Standards of Care
  6. JAMA Network Open, 2023 -- Smoking Cessation Duration and Diabetic Microvascular Complications
  7. PMC, 2023 -- The association between smoking and diabetic neuropathy: a systematic review and meta-analysis
  8. https://www.guideline.care/images-recos/standards-of-care-2026.pdf
  9. Smoking Cessation Duration and Diabetic Microvascular Complications | Diabetes and Endocrinology | JAMA Network Open | JAMA Network
  10. The association between smoking and diabetic neuropathy: a systematic review and meta-analysis - PMC

Original Source(s)

Related Content